BRIEF-Catalyst Pharmaceuticals Posts Q4 EPS Of $0.11

Reuters · 03/15/2021 21:37
BRIEF-Catalyst Pharmaceuticals Posts Q4 EPS Of $0.11

- Catalyst Pharmaceuticals Inc CPRX.O:

  • CATALYST PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND YEAR-END 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

  • Q4 EARNINGS PER SHARE $0.11

  • Q4 EARNINGS PER SHARE ESTIMATE $0.09 -- REFINITIV IBES DATA

  • Q4 REVENUE $31 MILLION VERSUS REFINITIV IBES ESTIMATE OF $30.4 MILLION

  • Q4 NON-GAAP EARNINGS PER SHARE $0.12 EXCLUDING ITEMS

  • CATALYST PHARMACEUTICALS- AT DEC 31, 2020, CO HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS OF $140.3 MILLION AND NO FUNDED DEBT

Source text for Eikon: ID:nGNX38yDpG

Further company coverage: CPRX.O


((Reuters.Briefs@thomsonreuters.com;))